• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Fred Hutchinson Cancer Research Center appoints new board members

Fred Hutchinson Cancer Research Center appoints new board members

June 25, 2013
CenterWatch Staff

Former Washington governor Chris Gregoire has been appointed to Fred Hutchinson Cancer Research Center's board of trustees. In addition to serving two terms as governor, Gregoire served three terms as attorney general. She is among four new Fred Hutch board members appointed for fiscal year 2013-2014, which brings the total number of those serving from 16 to 20. Their terms begin July.

The other new board members are former telecommunications executive Theresa "Terry" Gillespie, information technology venture capitalist Matt McIlwain and Norman Metcalfe, a real estate financier and investor.

Gillespie, managing director of Bellevue-based Trilogy Partnership, spent more than a decade at Western Wireless Corp., where she held positions from chief financial officer to vice chairman and director.

McIlwain is managing director of the Madrona Venture Group in Seattle, which invests in early stage information technology companies in the Pacific Northwest.

Metcalfe has background in finance and investments. He is director of The Ryland Group, a nationwide homebuilder, and the Tejon Ranch Company, a diversified real estate development and agribusiness company in Southern California. Previously he was vice chairman and chief financial officer of the Irvine Company, a real estate and community development company.

In addition to its new members, the board of trustees has appointed new leadership. Paula Reynolds, former vice chair of the board, has been appointed chair. Reynolds is former chair and chief executive officer of Safeco and currently is president and chief executive officer of PreferWest, a business advisory group. She succeeds Douglas Walker, former chief executive officer and chairman of software company WRQ, as board chair.

Jim Sinegal, co-founder and former chief executive officer of Costco, an international retail chain, has been appointed vice chair. He is also a member of the board's executive committee.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing